↓ Skip to main content

Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

Overview of attention for article published in Cancer Chemotherapy & Pharmacology, October 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
24 Mendeley
Title
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen
Published in
Cancer Chemotherapy & Pharmacology, October 2003
DOI 10.1007/s00280-003-0658-0
Authors

Marc Ychou, Jacqueline Duffour, Andrew Kramar, Charles Debrigode, Sophie Gourgou, Fran�oise Bressolle, Fr�d�ric Pinguet

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 8%
China 1 4%
United Kingdom 1 4%
Unknown 20 83%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 25%
Other 6 25%
Student > Ph. D. Student 2 8%
Unspecified 2 8%
Student > Master 2 8%
Other 6 25%
Readers by discipline Count As %
Medicine and Dentistry 7 29%
Unspecified 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Biochemistry, Genetics and Molecular Biology 3 13%
Agricultural and Biological Sciences 2 8%
Other 6 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2016.
All research outputs
#1,781,953
of 11,059,685 outputs
Outputs from Cancer Chemotherapy & Pharmacology
#68
of 1,525 outputs
Outputs of similar age
#35,988
of 152,774 outputs
Outputs of similar age from Cancer Chemotherapy & Pharmacology
#2
of 16 outputs
Altmetric has tracked 11,059,685 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,525 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,774 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.